IBG RESEARCHER RECEIVED THE HORIZON EUROPE JOINT PROGRAM OF NEURODEGENERATIVE DISEASE FUND

Jan. 12, 2024

IBG Researcher Receıved The Horızon Europe Joınt Program Of Neurodegeneratıve Dısease Fund.

Projects supported by the Joint Program of Neurodegenerative Disease under the European Union joint initiative program in the field of Neurodegenerative Diseases within the scope of the 2023 call "Large Scale Analysis of Omics Data for Drug-Target Finding in Neurodegenerative Diseases" has been announced. The project titled "Deciphering the Chemoproteomics and Chemo transcriptomics of Anti-Alzheimer Drugs for Novel Druggable Target Identification and Biomarkers Development" of the iBG researcher Prof. Dr. Şermin GENÇ has received the fund of 1.8 million Euros.

Link: https://neurodegenerationresearch.eu/initiatives/annual-calls-for-proposals/closed-calls/2023-research-call-on-large-scale-analysis-of-omics-data-for-drug-target-finding-in-neurodegenerative-diseases/large-scale-analysis-of-omics-data-for-drug-target-finding-in-neurodegenerative-diseases-projects/